Back to search

Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen.

Data up to Jan 2025

Published1996
Citations992
References24

Total Citations Per Year

Abstract

References (24)

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

1993 • 2,828 citations

IgG or IgM monoclonal antibodies reactive with different determinants on the molecular complex bearing Lyt 2 antigen block T cell-mediated cytolysis in the absence of complement.

1980 • 835 citations

Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4

1991 • 733 citations

Human papillomavirus type 16 DNA sequence

1985 • 718 citations

The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells

1991 • 592 citations

Immunology: The ins and outs of antigen processing and presentations

1986 • 498 citations

Identification of two lysosomal membrane glycoproteins.

1985 • 475 citations

The biosynthetic pathway of MHC class II but not class I molecules intersects the endocytic route

1990 • 445 citations

Follicular Dendritic Cells as Accessory Cells

1990 • 351 citations

Role for intracellular proteases in the processing and transport of class II HLA antigens.

1988 • 336 citations

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells.

1985 • 295 citations

Glycoproteins of the lysosomal membrane.

1985 • 294 citations

Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.

1994 • 287 citations

T and B memory cells

1994 • 285 citations

Accumulation of membrane glycoproteins in lysosomes requires a tyrosine residue at a particular position in the cytoplasmic tail.

1990 • 272 citations

The binary logic of antigen processing and presentation to T cells

1990 • 235 citations

In vivo priming of two distinct antitumor effector populations: the role of MHC class I expression.

1994 • 196 citations

The motif Tyr-X-X-hydrophobic residue mediates lysosomal membrane targeting of lysosome-associated membrane protein 1.

1993 • 169 citations

The NK-1.1(-) mouse: a model to study differentiation of murine NK cells.

1986 • 165 citations

Immunization against human papillomavirus type 16 tumor cells with recombinant vaccinia viruses expressing E6 and E7

1991 • 160 citations

Melanoma‐specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by epstein‐barr virus‐transformed B cells

1994 • 86 citations

Immunology of the human papilloma virus in relation to cancer

1994 • 77 citations

The effect of class II gene transfection on the tumourigenicity of the H-2K-negative mouse leukaemia cell line K36.16.

1991 • 46 citations

Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2.

1993 • 42 citations

Cited By (0)

No citing papers found in database

Treatment of established tumors with a novel vaccine that enhances major… (1996) – PubMed | Metascience Observatory Explorer